Prelude Therapeutics
Price & Volume
Stats
See more| 52W Range | $1.66-$5.83 |
| Market Cap | $204.8M |
| Shares Short | 566,883 |
Financials
See more| Revenue (12 Mos) | $0 |
| Revenue Growth (YoY) | 0% |
| Gross Profit (12 Mos) | $0 |
| Diluted EPS | -$1.86 |
News
See moreYahoo Finance • 8 months ago
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Prelude Therapeutics Incorporated (NASDAQ: PRLD) and Encourages Investors to Contact the Firm
Yahoo Finance • 8 months ago
Prelude Therapeutics Insiders Are Down US$149k But Regain Some Losses
Yahoo Finance • 8 months ago
Investor Alert: Abbott Cooper PLLC Investigates Prelude Therapeutics Incorporated; Urges Prelude Stockholders to Contact Abbott Cooper Regarding Their Legal Rights
Yahoo Finance • 8 months ago
Q3 2023 Abcellera Biologics Inc Earnings Call
About
| CEO | Dr. Krishna Vaddi D.V.M., Ph.D. |
| Address | 175 Innovation Boulevard, Wilmington, DE, United States, 19805 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Full-Time Employees | 128 |
